Related Experiment Video
Updated: Apr 30, 2026

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line
Ying Wang1, Qing-Yu He2, Jen-Fu Chiu3
1State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Abstract:
Saponins have shown promise in cancer prevention and therapy; however, little is known about the detailed signaling pathways underlying their anticancer activities. In the present study, we examined the mechanisms of action of dioscin, a glucosides saponin isolated from Polygonatum zanlanscianense pump, in human myeloblast leukemia HL-60 cells. Dioscin suppressed HL-60 cell growth in a dose-dependent manner. This inhibition was due to the induction of apoptosis as revealed by the externalization of phosphatidylserine, and cleavages of lamin A/C and PARP-1. Treatment with dioscin induced apoptosis through activation of caspases 3, 7, 8, 9, and 10. Phosphorylation of p38 MAPK and JNK contributed to dioscin-induced apoptosis upstream of caspase activation. Using various inhibitors and antioxidant agents, we found that mitochondrial derived reactive oxygen species and depletion of mitochondrial transmembrane potential lead to the phosphorylation of p38 MAPK and JNK. Taken together, our results demonstrated that dioscin induces apoptosis by activation of p38 MAPK and JNK through the caspase-dependent mitochondrial death pathway. This work suggests that dioscin may be used as a drug lead for the treatment of myeloblast leukemia.
Insights
Dioscin, a saponin, effectively inhibits leukemia cell growth by triggering apoptosis. This occurs through the activation of specific signaling pathways, suggesting its potential as a novel cancer therapy drug lead.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Saponins show potential in cancer therapy, but their detailed mechanisms are unclear.
- Understanding signaling pathways is crucial for developing novel anticancer agents.
Purpose of the Study:
- To investigate the anticancer mechanisms of dioscin in human myeloblast leukemia HL-60 cells.
- To elucidate the specific signaling pathways involved in dioscin's cytotoxic effects.
Main Methods:
- Cell viability assays to assess growth inhibition.
- Apoptosis assays including phosphatidylserine externalization and caspase activation.
- Western blotting to detect protein phosphorylation (p38 MAPK, JNK) and cleavage (PARP-1, lamin A/C).
- Mitochondrial function analysis using inhibitors and antioxidants.
Main Results:
- Dioscin suppressed HL-60 cell growth dose-dependently.
- Dioscin induced apoptosis via caspase activation (3, 7, 8, 9, 10) and mitochondrial pathway.
- Mitochondrial reactive oxygen species and membrane potential loss mediated p38 MAPK and JNK phosphorylation.
Conclusions:
- Dioscin induces apoptosis in leukemia cells through p38 MAPK and JNK activation via the mitochondrial pathway.
- Dioscin's mechanism involves caspase-dependent signaling initiated by mitochondrial dysfunction.
- Dioscin shows promise as a potential therapeutic agent for myeloblast leukemia.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
Mitogens and the Cell Cycle
Signal Transduction: Overview
Typically, signal transduction involves three...

